Alerce Investment Management’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-830,466
| Closed | -$5.51M | – | 6 |
|
|
2024
Q1 | $5.51M | Hold |
830,466
| – | – | 5.79% | 4 |
|
|
2023
Q4 | $2.53M | Hold |
830,466
| – | – | 3.37% | 5 |
|
|
2023
Q3 | $1.26M | Hold |
830,466
| – | – | 2.16% | 6 |
|
|
2023
Q2 | $1.49M | Hold |
830,466
| – | – | 1.93% | 6 |
|
|
2023
Q1 | $1.03M | Hold |
830,466
| – | – | 1.36% | 6 |
|
|
2022
Q4 | $1.97M | Sell |
830,466
-6
| -0% | -$14 | 2.26% | 6 |
|
|
2022
Q3 | $3.43M | Hold |
830,472
| – | – | 3.31% | 6 |
|
|
2022
Q2 | $4.32M | Hold |
830,472
| – | – | 8.01% | 5 |
|
|
2022
Q1 | $8.51M | Hold |
830,472
| – | – | 14.42% | 2 |
|
|
2021
Q4 | $9.35M | Hold |
830,472
| – | – | 9.51% | 4 |
|
|
2021
Q3 | $16.9M | Hold |
830,472
| – | – | 11.6% | 3 |
|
|
2021
Q2 | $20.8M | Hold |
830,472
| – | – | 11.27% | 3 |
|
|
2021
Q1 | $23.8M | Buy |
830,472
+450,000
| +118% | +$12.9M | 10.51% | 3 |
|
|
2020
Q4 | $7.91M | Buy |
+380,472
| New | +$7.91M | 3.12% | 5 |
|